Webinars and Videos
Claim interpretation, antibody sufficiency and medical use disclaimers ǀ European biotech patent case law series (July 2025)
European patent attorneys Matthew Caines and Nathaniel Wand present our latest webinar update of new and important European Patent Office (EPO) biotechnology patent case law.
The webinar includes discussion of the latest European biotech patent case law developments including:
- G 1/24: claim interpretation and relevance of the description
- T 0435/20 & T 0326/22: sufficiency of antibody claims defined by discontinuous epitopes
- T 1390/22: distinguishing second medical use claims using a disclaimer
System requirements
To view our webinars we recommend the following internet browsers:
- Google Chrome (most recent 2 versions).
- Mozilla Firefox (most recent 2 versions).
- Apple Safari (most recent 2 versions).
- Microsoft Edge (most recent 2 versions).
Patent-Newsletter
Neueste Ausgabe